Merck has made the decision to end 2 clinical trials evaluating its programmed death receptor-1 (PD-1)-blocking antibody, Keytruda ® (pembrolizumab). The Company is discontinuing the phase 3 ...

Routine annual influenza vaccination is recommended for all patients 6 months of age and older who have no contraindications.

The vaccine is administered percutaneously using a bifurcated needle that is dipped into the vaccine solution; the skin is then pricked several times in the upper arm.

Cumulative incidence of symptomatic stone event decreased with increasing calcium change after thiazide prescription ...

(HealthDay News) — Counties with high pharmacy desert densities also face social vulnerability and health care provider shortages, according to a research letter published online Aug. 23 in JAMA ...

According to Lilly, a 4-week supply of Zepbound 2.5mg single-dose vial is $399 ($99.75 per vial) and a 4-week supply of Zepbound 5mg single-dose vial is $549 ($137.25 per vial).

Inclisiran is a chemically synthesized small interfering RNA that targets proprotein convertase subtilisin-kexin type 9 messenger RNA.

Most psychedelics were better than placebo in psychedelic trials, but in antidepression trials of escitalopram, only high-dose psilocybin was better than placebo. (HealthDay News) — Patients ...

As a summer surge in COVID cases begins to ebb and Americans brace themselves for yet another wave of infections this winter, more free COVID tests will soon be available to all.

The researchers found that after treatment of qualifying prodrome events, participants after ubrogepant treatment had a significantly greater ability to function normally over 24 hours than those ...

In both the groups with heart failure (HF) with reduced ejection fraction and HF with preserved ejection fraction, semaglutide treatment resulted in improved outcomes in MACE and the composite HF ...